Article content material
TORONTO — Mednow Inc. (“Mednow” or the “Firm”) (TSXV:MNOW), Canada’s on-demand digital pharmacy, is happy to announce the Firm has accomplished the acquisition (the “Acquisition“), beforehand introduced on March 7, 2022, of all the issued and excellent voting shares of Mednow Pharmacy Inc. (“Mednow East”), for an mixture money fee of roughly C$65,578 and the Firm’s settlement to transform roughly C$1,374,422 owed by Mednow East to the Firm pursuant to a pharmacy settlement dated September 15, 2020, as amended October 30, 2020 (the “Pharmacy Settlement”) right into a non-interest bearing on-demand convertible promissory notice (the “Notice”). On the sole discretion of the Firm, the Notice may be happy by the fee of money or the issuance of two,095 Class A Particular Shares of Mednow East at a deemed value of $655.78 per share. Mednow East’s income and bills will likely be consolidated with these of the Firm and the Pharmacy Settlement between the 2 events will likely be terminated
Article content material
Mednow East is a Toronto firm that operates an internet pharmacy, delivering prescriptions within the Province of Ontario. Mednow East has its enterprise headquarters in Toronto and employs Mednow’s advertising and know-how platform for lead technology, prescription achievement and buyer companies.
“We’re persevering with to execute our plan for a nationwide presence throughout Canada and we’re thrilled to be consolidating Mednow East below our platform. As we add service to our digital first healthcare platform, we’re additionally concurrently working to develop our geographical attain to change into a family title in Canadian healthcare,” stated Karim Nassar, Chief Government Officer.
As Amir Ali Reyhany-Bozorg and Felipe Campusano are administrators of the Firm and Karim Nassar is the Chief Government Officer of the Firm, and every are additionally shareholders of Mednow East, the Acquisition is a associated celebration transaction below Multilateral Instrument 61-101 – Safety of Minority Securityholders in Particular Transactions (“MI 61-101“). The Firm is exempt from the formal valuation and minority shareholder approval necessities imposed by MI 61-101 pursuant to the exemptions in part 5.5(a) and 5.7(a) of MI 61-101, as neither the honest market worth of the shares of Mednow East, nor the consideration paid therefor, exceeds 25% of the Firm’s market capitalization.
About Mednow Inc.
Mednow is a healthcare know-how firm providing digital entry with a excessive normal of care. Designed with accessibility and high quality of care in thoughts, Mednow.ca gives digital pharmacy and telemedicine companies in addition to physician house visits by means of an interdisciplinary method to healthcare that’s targeted on the affected person expertise. Mednow’s companies embody free at-home supply of medicines, a user-friendly interface for straightforward add, switch, and refill of prescriptions, entry to healthcare professionals by means of an intuitive chat expertise, a specialised PillSmart™ system that packages prescriptions and nutritional vitamins by date and time, and physician consultations.
To study extra, comply with Mednow on Fb, Twitter, LinkedIn , and Instagram, or go to our web site at www.mednow.ca/.
Neither TSX Enterprise Trade nor its Regulation Companies Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Trade) accepts accountability for the adequacy or accuracy of this launch.
Article content material
Cautionary Notice Concerning Ahead-Trying Info
This launch contains sure statements and data that will represent forward-looking info inside the which means of relevant Canadian securities legal guidelines. All statements on this information launch, aside from statements of historic details, together with statements concerning future estimates, plans, goals, timing, assumptions or expectations of future efficiency, together with with out limitation, the assertion concerning the intention to proceed to execute Mednow’s plan for a nationwide presence throughout Canada; and to develop its geographical attain to change into a family title in Canadian healthcare. Usually, forward-looking statements and data may be recognized by way of forward-looking terminology equivalent to “intends” or “anticipates”, or variations of such phrases and phrases or statements that sure actions, occasions or outcomes “might”, “might”, “ought to”, “would” or “happen”. Ahead-looking statements are primarily based on sure materials assumptions and evaluation made by the Firm and the opinions and estimates of administration as of the date of this press launch, together with that the Firm will receive the approvals required to execute its growth plans, that common financial and market situations won’t change in an hostile method, political and regulatory stability, stability in monetary and capital markets and that the Firm’s operations won’t be adversely impacted by COVID-19. These forward-looking statements are topic to recognized and unknown dangers, uncertainties and different elements that will trigger the precise outcomes, degree of exercise, efficiency or achievements of the Firm to be materially completely different from these expressed or implied by such forward-looking statements or forward-looking info. Vital elements that will trigger precise outcomes to differ, embody, with out limitation (a) public well being crises such because the COVID-19 pandemic might adversely impression the Firm’s enterprise and operations; (b) the volatility of world capital markets; (c) unanticipated prices; and (d) dangers referring to the extent and length of the battle in Japanese Europe and its impression on international markets. Though administration of the Firm has tried to determine essential elements that would trigger precise outcomes to vary materially from these contained in forward-looking statements or forward-looking info, there could also be different elements that trigger outcomes to not be as anticipated, estimated or meant. There may be no assurance that such statements will show to be correct, as precise outcomes and future occasions might differ materially from these anticipated in such statements. Accordingly, readers mustn’t place undue reliance on forward-looking statements and forward-looking info. Readers are cautioned that reliance on such info will not be applicable for different functions. The Firm doesn’t undertake to replace any forward-looking assertion, forward-looking info or monetary out-look which are included by reference herein, besides in accordance with relevant securities legal guidelines.
Investor Relations Contact:
Benjamin Ferdinand, Chief Monetary Officer
Lucy Chitilian, CFA, Head of Investor Relations